14. Stock Compensation (Details - Option activity) - Options [Member] - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
Stock options outstanding, beginning balance | 1,702,167 | |
Stock options issued | 2,395,000 | |
Stock options exercised | 0 | |
Stock options expired | 87,500 | |
Stock options outstanding, ending balance | 4,009,667 | |
Stock options exercisable | 1,108,996 | |
Weighted average remaining life, outstanding | 9 years 5 months 1 day | |
Weighted average remaining life, issued | 9 years 6 months 29 days | |
Weighted average remaining life, expired | 9 years 1 month 20 days | |
Weighted average remaining life, exercisable | 8 years 10 months 28 days | |
Weighted average exercise price, outstanding | $ 1.21 | |
Weighted average exercise price, issued | 1.00 | |
Weighted average exercise price, expired | 1.35 | |
Weighted average exercise price, outstanding | $ 1.09 | |
Weighted average exercise price, exercisable | $ 1.12 |
X | ||||||||||
- Definition Weighted average remaining life, expired No definition available.
|
X | ||||||||||
- Definition Weighted average remaining life, issued No definition available.
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|